E-LDL upregulates TOSO expression and enhances the survival of human macrophages

Biochemical and Biophysical Research Communications

Volumn 359, Issue 3, 2007, Pages 723-728

  Sigruener, Alexander ^a   Buechler, Christa ^a   Bared, Salim Maa ^a   Grandl, Margot ^a   Aslanidis, Charalampos ^a   Ugocsai, Peter ^a   Gehrmann, Mathias ^b   Schmitz, Gerd ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b SIEMENS AG   (Germany)

Author keywords

Apoptosis; E LDL; Macrophages; Ox LDL; Phagocytosis; TOSO

Indexed keywords

LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN; TOSO PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; UPREGULATION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL SURVIVAL; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; HYDROXYSTEROID DEHYDROGENASES; LIPOPROTEINS, LDL; MACROPHAGES; MEMBRANE PROTEINS; ORGAN SPECIFICITY; OXIDATION-REDUCTION; PHAGOCYTOSIS; RNA, MESSENGER; TRYPSIN; UP-REGULATION;

EID: 34250193295     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.169     Document Type: Article

References (31)

1. Ross R. Atherosclerosis is an inflammatory disease. Am. Heart J. 138 (1999) S419-S420
2. Goldstein J.L., Ho Y.K., Basu S.K., and Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad Sci. USA 76 (1979) 333-337
3. Libby P., Geng Y.J., Aikawa M., Schoenbeck U., Mach F., Clinton S.K., Sukhova G.K., and Lee R.T. Macrophages and atherosclerotic plaque stability. Curr. Opin. Lipidol. 7 (1996) 330-335
4. Gillotte-Taylor K., Boullier A., Witztum J.L., Steinberg D., and Quehenberger O. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J. Lipid Res. 42 (2001) 1474-1482
5. Ezaki M., Witztum J.L., and Steinberg D. Lipoperoxides in LDL incubated with fibroblasts that overexpress 15-lipoxygenase. J. Lipid Res. 36 (1995) 1996-2004
6. Liao H.S., Kodama T., and Geng Y.J. Expression of class A scavenger receptor inhibits apoptosis of macrophages triggered by oxidized low density lipoprotein and oxysterol. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1968-1975
7. Kinscherf R., Deigner H.P., Usinger C., Pill J., Wagner M., Kamencic H., Hou D., Chen M., Schmiedt W., Schrader M., Kovacs G., Kato K., and Metz J. Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J. 11 (1997) 1317-1328
8. Lagasse E., and Weissman I.L. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89 (1997) 1021-1031
9. Deigner H.P., Claus R., Bonaterra G.A., Gehrke C., Bibak N., Blaess M., Cantz M., Metz J., and Kinscherf R. Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis. FASEB J. 15 (2001) 807-814
10. Hamilton J.A., Myers D., Jessup W., Cochrane F., Byrne R., Whitty G., and Moss S. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 98-105
11. Hamilton J.A., Jessup W., Brown A.J., and Whitty G. Enhancement of macrophage survival and DNA synthesis by oxidized-low-density-lipoprotein (LDL)-derived lipids and by aggregates of lightly oxidized LDL. Biochem. J. 355 (2001) 207-214
12. Bhakdi S., Dorweiler B., Kirchmann R., Torzewski J., Weise E., Tranum-Jensen J., Walev I., and Wieland E. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J. Exp. Med. 182 (1995) 1959-1971
13. Torzewski M., Klouche M., Hock J., Messner M., Dorweiler B., Torzewski J., Gabbert H.E., and Bhakdi S. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 369-378
14. Horkko S., Bird D.A., Miller E., Itabe H., Leitinger N., Subbanagounder G., Berliner J.A., Friedman P., Dennis E.A., Curtiss L.K., Palinski W., and Witztum J.L. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103 (1999) 117-128
15. Bhakdi S. Complement and atherogenesis: the unknown connection. Ann. Med. 30 (1998) 503-507
16. Kapinsky M., Torzewski M., Buchler C., Duong C.Q., Rothe G., and Schmitz G. Enzymatically degraded LDL preferentially binds to CD14 (high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1004-1010
17. Klouche M., Gottschling S., Gerl V., Hell W., Husmann M., Dorweiler B., Messner M., and Bhakdi S. Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1376-1385
18. Stoyanova E., Tesch A., Armstrong V.W., and Wieland E. Enzymatically degraded low density lipoproteins are more potent inducers of egr-1 mRNA than oxidized or native low density lipoproteins. Clin. Biochem. 34 (2001) 483-490
19. Buechler C., Ritter M., Duong C.Q., Orso E., Kapinsky M., and Schmitz G. Adipophilin is a sensitive marker for lipid loading in human blood monocytes. Biochim. Biophys. Acta 1532 (2001) 97-104
20. Han S.R., Momeni A., Strach K., Suriyaphol P., Fenske D., Paprotka K., Hashimoto S.I., Torzewski M., Bhakdi S., and Husmann M. Enzymatically modified LDL induces cathepsin H in human monocytes: potential relevance in early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 661-667
21. Bared S.M., Buechler C., Boettcher A., Dayoub R., Sigruener A., Grandl M., Rudolph C., Dada A., and Schmitz G. Association of ABCA1 with syntaxin 13 and flotillin-1 and enhanced phagocytosis in tangier cells. Mol. Biol. Cell 15 (2004) 5399-5407
22. Buechler C., Ullrich H., Ritter M., Porsch-Oezcueruemez M., Lackner K.J., Barlage S., Friedrich S.O., Kostner G.M., and Schmitz G. Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes. Blood 97 (2001) 981-986
23. Bjorkerud B., and Bjorkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler. Thromb. Vasc. Biol. 16 (1996) 416-424
24. Kiener P.A., Davis P.M., Starling G.C., Mehlin C., Klebanoff S.J., Ledbetter J.A., and Liles W.C. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J. Exp. Med. 185 (1997) 1511-1516
25. Hitoshi Y., Lorens J., Kitada S.I., Fisher J., LaBarge M., Ring H.Z., Francke U., Reed J.C., Kinoshita S., and Nolan G.P. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity 8 (1998) 461-471
26. Song Y., and Jacob C.O. The mouse cell surface protein TOSO regulates Fas/Fas ligand-induced apoptosis through its binding to Fas-associated death domain. J. Biol. Chem. 280 (2005) 9618-9626
27. Buechler C., Bared S.M., Aslanidis C., Ritter M., Drobnik W., and Schmitz G. Molecular and functional interaction of the ATP-binding cassette transporter A1 with Fas-associated death domain protein. J. Biol. Chem. 277 (2002) 41307-41310
28. Hamon Y., Broccardo C., Chambenoit O., Luciani M.F., Toti F., Chaslin S., Freyssinet J.M., Devaux P.F., McNeish J., Marguet D., and Chimini G. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat. Cell Biol. 2 (2000) 399-406
29. Horiuchi S., Sakamoto Y., and Sakai M. Scavenger receptors for oxidized and glycated proteins. Amino Acids 25 (2003) 283-292
30. Bhakdi S., Torzewski M., Paprotka K., Schmitt S., Barsoom H., Suriyaphol P., Han S.R., Lackner K.J., and Husmann M. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence. Circulation 109 (2004) 1870-1876
31. Bing H., Wang J., Zhang C., and Cai H. Positive correlation between in vivo oxidized LDL and LDL immune complexes. Clin. Biochem. 37 (2004) 72-75